Chemomab Therapeutics's total assets for Q2 2025 were $11.13M, a decrease of -13.18% from the previous quarter. CMMB total liabilities were $1.43M for the fiscal quarter, a -41.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.